Werner Krenger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Werner Krenger has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- George Hollander
Universitäts-Kinderspital beider Basel (UKBB)
5 shared publications Georg A. HollänDer
From the Departments of Research and Clinical-Biological Sciences, Center for Biomedicine, University of Basel, Basel, Switzerland; University Children's Hospital (UKBB), Basel, Switzerland; and the Institute of Anatomy, University of Basel, Basel, Switzerland
3 shared publicationsLuca Piali
From the Laboratory of Pediatric Immunology, The Children's University Hospital, and the Department of Research, Kantonsspital Basel, Basel University, Switzerland
2 shared publications- Lukas T. Jeker
Department of Biomedicine, Basel University Hospital and University of Basel, Hebelstrasse 20, CH-4031 Basel, Switzerland
2 shared publications Simona Rossi
From the Laboratory of Pediatric Immunology, The Children's University Hospital, and the Department of Research, Kantonsspital Basel, Basel University, Switzerland
2 shared publications- Andrei V. Gudkov
Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
1 shared publication
Latest Publications
- Open Access
- 13 July 2021
- Published by Wiley in HemaSphere
- Vol. 5 (8) , e613
Sphingosine-1-phosphate Receptor-1 Agonist Averts the De Novo Generation of Autoreactive T-cells in Murine Acute Graft-versus-Host Disease
- 13 July 2021
- Published by Wiley in HemaSphere
- Vol. 5 (8) , e613
Open AccessSphingosine-1-phosphate Receptor-1 Agonist Averts the De Novo Generation of Autoreactive T-cells in Murine Acute Graft-versus-Host Disease
- Open Access
- 23 June 2011
- Published by American Society of Hematology in Blood
- Vol. 117 (25) , 6768-6776
Thymic T-cell development in allogeneic stem cell transplantation
Cytoreductive conditioning regimens used in the context of allogeneic hematopoietic cell transplantation (HCT) elicit deficits in innate and adaptive immunity, which predispose patients to infections. As such, transplantation outcomes depend vitally on the successful reconstruction of immune competence. Restoration of a normal peripheral T-cell pool after HCT is a slow process that requires the de novo production of naive T cells in a functionally competent thymus. However, there are several challenges to this regenerative process. Most notably, advanced age, the cytotoxic pretransplantation conditioning, and posttransplantation alloreactivity are risk factors for T-cell immune deficiency as they independently interfere with normal thymus function. Here, we discuss preclinical allogeneic HCT models and clinical observations that have contributed to a better understanding of the transplant-related thymic dysfunction. The identification of the cellular and molecular mechanisms that control regular thymopoiesis but are altered in HCT patients is expected to provide the basis for new therapies that improve the regeneration of the adaptive immune system, especially with functionally competent, naive T cells.
- 23 June 2011
- Published by American Society of Hematology in Blood
- Vol. 117 (25) , 6768-6776
Open AccessThymic T-cell development in allogeneic stem cell transplantation
Cytoreductive conditioning regimens used in the context of allogeneic hematopoietic cell transplantation (HCT) elicit deficits in innate and adaptive immunity, which predispose patients to infections. As such, transplantation outcomes depend vitally on the successful reconstruction of immune competence. Restoration of a normal peripheral T-cell pool after HCT is a slow process that requires the de novo production of naive T cells in a functionally competent thymus. However, there are several challenges to this regenerative process. Most notably, advanced age, the cytotoxic pretransplantation conditioning, and posttransplantation alloreactivity are risk factors for T-cell immune deficiency as they independently interfere with normal thymus function. Here, we discuss preclinical allogeneic HCT models and clinical observations that have contributed to a better understanding of the transplant-related thymic dysfunction. The identification of the cellular and molecular mechanisms that control regular thymopoiesis but are altered in HCT patients is expected to provide the basis for new therapies that improve the regeneration of the adaptive immune system, especially with functionally competent, naive T cells.
- Open Access
- 19 July 2010
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 140 (2930) , w13051
The role of the thymus in allogeneic haematopoietic stem cell transplantation
Allogeneic haematopoietic stem cell transplantation (HSCT) is used to treat an increasing number of congenital and acquired disorders of the haematopoietic system. Even though cytoreductive conditioning regimens vary in intensity, all clinically used protocols invariably cause side effects that compromise transiently or long-term the response of the natural and the adaptive immune systems. However, in the context of the reconstruction of immunity, the generation of naïve T cells constitutes a slow process, and requires a functionally competent thymus. Unfortunately, regular thymic function is frequently suppressed by transplant-related toxicities. Most notably, graft-versus-host disease (GVHD) causes a state of posttransplantation immune deficiency. Here we discuss preclinical allogeneic HSCT models and clinical observations that have contributed to a detailed understanding of the cellular and molecular mechanisms responsible for the thymic dysfunction caused by acute GVHD. An in-depth knowledge of the mechanisms that control regular thymopoiesis and, conversely, affect thymus function is expected to provide the factual basis for the design of innovative therapies to recover T-cell numbers and function following allogeneic HSCT.
- 19 July 2010
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 140 (2930) , w13051
Open AccessThe role of the thymus in allogeneic haematopoietic stem cell transplantation
Allogeneic haematopoietic stem cell transplantation (HSCT) is used to treat an increasing number of congenital and acquired disorders of the haematopoietic system. Even though cytoreductive conditioning regimens vary in intensity, all clinically used protocols invariably cause side effects that compromise transiently or long-term the response of the natural and the adaptive immune systems. However, in the context of the reconstruction of immunity, the generation of naïve T cells constitutes a slow process, and requires a functionally competent thymus. Unfortunately, regular thymic function is frequently suppressed by transplant-related toxicities. Most notably, graft-versus-host disease (GVHD) causes a state of posttransplantation immune deficiency. Here we discuss preclinical allogeneic HSCT models and clinical observations that have contributed to a detailed understanding of the cellular and molecular mechanisms responsible for the thymic dysfunction caused by acute GVHD. An in-depth knowledge of the mechanisms that control regular thymopoiesis and, conversely, affect thymus function is expected to provide the factual basis for the design of innovative therapies to recover T-cell numbers and function following allogeneic HSCT.
- 31 October 2008
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 30 (4) , 439-456
The immunopathology of thymic GVHD
The clinical success of allogeneic hematopoietic stem cell transplantation (HSCT) depends on the appropriate reconstitution of the host’s immune system. While recovery of T-cell immunity may occur in transplant recipients via both thymus-dependent and thymus-independent pathways, the regeneration of a population of phenotypically naive T cells with a broad receptor repertoire relies entirely on the de novo generation of T-cells in the thymus. Preclinical models and clinical studies of allogeneic HSCT have identified the thymus as a target of graft-versus-host disease (GVHD), thus limiting T-cell regeneration. The present review focuses on recent insight into how GVHD affects thymic structure and function and how this knowledge may aid in the design of new strategies to improve T-cell reconstitution following allogeneic HSCT.
- 31 October 2008
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 30 (4) , 439-456
The immunopathology of thymic GVHD
The clinical success of allogeneic hematopoietic stem cell transplantation (HSCT) depends on the appropriate reconstitution of the host’s immune system. While recovery of T-cell immunity may occur in transplant recipients via both thymus-dependent and thymus-independent pathways, the regeneration of a population of phenotypically naive T cells with a broad receptor repertoire relies entirely on the de novo generation of T-cells in the thymus. Preclinical models and clinical studies of allogeneic HSCT have identified the thymus as a target of graft-versus-host disease (GVHD), thus limiting T-cell regeneration. The present review focuses on recent insight into how GVHD affects thymic structure and function and how this knowledge may aid in the design of new strategies to improve T-cell reconstitution following allogeneic HSCT.
- 1 February 2007
- Published by Hogrefe Publishing Group in Praxis
- Vol. 96 (6) , 199-204
Fremd und Selbst – Die Herausforderung für das Immunsystem
Im normalen Individuum erbringt das Immunsystem eine Höchstleistung, in dem es erfolgreich zwischen krankheitsauslösenden Erregern («Fremd») und Produkten des eigenen Körpers («Selbst») unterscheidet. Die Aufgabe, Fremdantigen spezifisch erkennen zu können und eine sinnvolle Abwehrreaktion einzuleiten, wird hauptsächlich von T-Lymphozyten wahrgenommen. In etwa 7% der Bevölkerung funktioniert dies jedoch nicht oder nur teilweise, weil das T-Zell-Abwehrsystem ein falsches Ziel verfolgt: das «Selbst». Bei den betroffenen Patienten entstehen in der Folge Autoimmunerkrankungen verschiedenster Ausprägung, zum Beispiel Gelenkrheuma, Multiple Sklerose, Diabetes, Schuppenflechte oder entzündliche Darmerkrankungen. Aufgrund der klinischen Bedeutung dieser Erkrankungen ist es notwendig, die Taktiken zu begreifen, auf welche das Immunsystem im Normalfall zur Vermeidung der Autoimmunität zurückgreifen kann. Ziel dieser kurzen Übersichtsarbeit ist es, bestehende und neue Erkenntnisse über die zelluläre und molekulare Basis der «Fremd»/«Selbst»-Diskrimination durch T-Lymphozyten zusammenzufassen und zu erörtern. Toleranz gegen Selbstantigene wird auf zwei Ebenen hergestellt: im Thymus und in der Peripherie. Im Thymus werden die T-Zellkandidaten zwei sequenziellen Selektionsschritten unterzogen, um die nutzlosen oder gar schädlichen Spezifitäten von den Nützlichen zu trennen. Diese zwei Prüfungen werden als positive und negative Selektion bezeichnet, wobei die dazu notwendigen Signale von kortikalen und medullären Thymusepithelzellen bereitgestellt werden. Als Folge dieser Prozesse soll ein Repertoire an T-Lymphozyten entstehen, welches in der Lage ist, auf fremde Antigene reagieren zu können und gleichzeitig tolerant gegen Produkte des eigenen Körpers zu sein. Diese thymische Toleranzinduktion wird auch als zentrale Toleranz bezeichnet. Die zentrale Toleranzinduktion ist jedoch unvollständig und so können autoaggressive T-Zellen aus dem Thymus entweichen. Diese müssen in der Peripherie durch ein Netzwerk unterschiedlicher Kontrollmechanismen, zu welchem u.a. auch regulatorische T-Zellen gehören, unter Kontrolle gehalten werden (periphere Toleranz). Die Anzahl und Bandbreite des peripheren autoaggressiven T-Zellrepertoires wird jedoch durch einen besonderen Mechanismus beschränkt: Thymische medulläre Epithelzellen sind interessanterweise befähigt, einen Teil des peripheren Selbstantigenrepertoires zu reproduzieren. Dies betrifft zum Beispiel Insulin, welches sonst ausschliesslich in der Bauchspeicheldrüse hergestellt wird. Mittels dieses Vorgangs, welcher als «promiskuitive»oder «ektope»Genexpression bezeichnet wird, stellen thymische Epithelzellen den zu selektionierenden T-Zellen ein molekulares (Teil-)Abbild der Peripherie – eines «Schattens des immunologischen Selbst»- zur Verfügung. Somit ist der Thymus befähigt, zentrale Toleranz gegen eine Vielzahl organspezifischer Antigene herzustellen. Dieser erst kürzlich erkannte Zusammenhang stellt das Immunsystem in ein völlig neues Licht, was die Toleranzinduktion gegen gewebstypische Selbstantigene – und damit die Prävention organspezifischer Autoimmunerkrankungen – betrifft.
- 1 February 2007
- Published by Hogrefe Publishing Group in Praxis
- Vol. 96 (6) , 199-204
Fremd und Selbst – Die Herausforderung für das Immunsystem
Im normalen Individuum erbringt das Immunsystem eine Höchstleistung, in dem es erfolgreich zwischen krankheitsauslösenden Erregern («Fremd») und Produkten des eigenen Körpers («Selbst») unterscheidet. Die Aufgabe, Fremdantigen spezifisch erkennen zu können und eine sinnvolle Abwehrreaktion einzuleiten, wird hauptsächlich von T-Lymphozyten wahrgenommen. In etwa 7% der Bevölkerung funktioniert dies jedoch nicht oder nur teilweise, weil das T-Zell-Abwehrsystem ein falsches Ziel verfolgt: das «Selbst». Bei den betroffenen Patienten entstehen in der Folge Autoimmunerkrankungen verschiedenster Ausprägung, zum Beispiel Gelenkrheuma, Multiple Sklerose, Diabetes, Schuppenflechte oder entzündliche Darmerkrankungen. Aufgrund der klinischen Bedeutung dieser Erkrankungen ist es notwendig, die Taktiken zu begreifen, auf welche das Immunsystem im Normalfall zur Vermeidung der Autoimmunität zurückgreifen kann. Ziel dieser kurzen Übersichtsarbeit ist es, bestehende und neue Erkenntnisse über die zelluläre und molekulare Basis der «Fremd»/«Selbst»-Diskrimination durch T-Lymphozyten zusammenzufassen und zu erörtern. Toleranz gegen Selbstantigene wird auf zwei Ebenen hergestellt: im Thymus und in der Peripherie. Im Thymus werden die T-Zellkandidaten zwei sequenziellen Selektionsschritten unterzogen, um die nutzlosen oder gar schädlichen Spezifitäten von den Nützlichen zu trennen. Diese zwei Prüfungen werden als positive und negative Selektion bezeichnet, wobei die dazu notwendigen Signale von kortikalen und medullären Thymusepithelzellen bereitgestellt werden. Als Folge dieser Prozesse soll ein Repertoire an T-Lymphozyten entstehen, welches in der Lage ist, auf fremde Antigene reagieren zu können und gleichzeitig tolerant gegen Produkte des eigenen Körpers zu sein. Diese thymische Toleranzinduktion wird auch als zentrale Toleranz bezeichnet. Die zentrale Toleranzinduktion ist jedoch unvollständig und so können autoaggressive T-Zellen aus dem Thymus entweichen. Diese müssen in der Peripherie durch ein Netzwerk unterschiedlicher Kontrollmechanismen, zu welchem u.a. auch regulatorische T-Zellen gehören, unter Kontrolle gehalten werden (periphere Toleranz). Die Anzahl und Bandbreite des peripheren autoaggressiven T-Zellrepertoires wird jedoch durch einen besonderen Mechanismus beschränkt: Thymische medulläre Epithelzellen sind interessanterweise befähigt, einen Teil des peripheren Selbstantigenrepertoires zu reproduzieren. Dies betrifft zum Beispiel Insulin, welches sonst ausschliesslich in der Bauchspeicheldrüse hergestellt wird. Mittels dieses Vorgangs, welcher als «promiskuitive»oder «ektope»Genexpression bezeichnet wird, stellen thymische Epithelzellen den zu selektionierenden T-Zellen ein molekulares (Teil-)Abbild der Peripherie – eines «Schattens des immunologischen Selbst»- zur Verfügung. Somit ist der Thymus befähigt, zentrale Toleranz gegen eine Vielzahl organspezifischer Antigene herzustellen. Dieser erst kürzlich erkannte Zusammenhang stellt das Immunsystem in ein völlig neues Licht, was die Toleranzinduktion gegen gewebstypische Selbstantigene – und damit die Prävention organspezifischer Autoimmunerkrankungen – betrifft.
- Open Access
- 9 January 2007
- Published by American Society of Hematology in Blood
- Vol. 109 (9) , 3803-3811
Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells
The systemic administration of keratinocyte growth factor (KGF) enhances T-cell lymphopoiesis in normal mice and mice that received a bone marrow transplant. KGF exerts protection to thymic stromal cells from cytoablative conditioning and graft-versus-host disease–induced injury. However, little is known regarding KGF's molecular and cellular mechanisms of action on thymic stromal cells. Here, we report that KGF induces in vivo a transient expansion of both mature and immature thymic epithelial cells (TECs) and promotes the differentiation of the latter type of cells. The increased TEC numbers return within 2 weeks to normal values and the microenvironment displays a normal architectural organization. Stromal changes initiate an expansion of immature thymocytes and permit regular T-cell development at an increased rate and for an extended period of time. KGF signaling in TECs activates both the p53 and NF-κB pathways and results in the transcription of several target genes necessary for TEC function and T-cell development, including bone morphogenetic protein 2 (BMP2), BMP4, Wnt5b, and Wnt10b. Signaling via the canonical BMP pathway is critical for the KGF effects. Taken together, these data provide new insights into the mechanism(s) of action of exogenous KGF on TEC function and thymopoiesis.
- 9 January 2007
- Published by American Society of Hematology in Blood
- Vol. 109 (9) , 3803-3811
Open AccessKeratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells
The systemic administration of keratinocyte growth factor (KGF) enhances T-cell lymphopoiesis in normal mice and mice that received a bone marrow transplant. KGF exerts protection to thymic stromal cells from cytoablative conditioning and graft-versus-host disease–induced injury. However, little is known regarding KGF's molecular and cellular mechanisms of action on thymic stromal cells. Here, we report that KGF induces in vivo a transient expansion of both mature and immature thymic epithelial cells (TECs) and promotes the differentiation of the latter type of cells. The increased TEC numbers return within 2 weeks to normal values and the microenvironment displays a normal architectural organization. Stromal changes initiate an expansion of immature thymocytes and permit regular T-cell development at an increased rate and for an extended period of time. KGF signaling in TECs activates both the p53 and NF-κB pathways and results in the transcription of several target genes necessary for TEC function and T-cell development, including bone morphogenetic protein 2 (BMP2), BMP4, Wnt5b, and Wnt10b. Signaling via the canonical BMP pathway is critical for the KGF effects. Taken together, these data provide new insights into the mechanism(s) of action of exogenous KGF on TEC function and thymopoiesis.
- 10 June 2006
- Vol. 136, 365-9
A short primer on early molecular and cellular events in thymus organogenesis and replacement.
Haematopoietic precursors have to undergo a complex series of maturational steps in the thymus before they exit into the periphery as functional T lymphocytes. Thymic stroma cells, the majority being of epithelial origin, provide the functional partners for the maturational progression along this differentiation pathway. Here we review some of the molecular and cellular mechanisms that account for thymus organogenesis and discuss a strategy to use thymic epithelial precursor cells for the regeneration of the thymic microenvironment.
- 10 June 2006
- Vol. 136, 365-9
A short primer on early molecular and cellular events in thymus organogenesis and replacement.
Haematopoietic precursors have to undergo a complex series of maturational steps in the thymus before they exit into the periphery as functional T lymphocytes. Thymic stroma cells, the majority being of epithelial origin, provide the functional partners for the maturational progression along this differentiation pathway. Here we review some of the molecular and cellular mechanisms that account for thymus organogenesis and discuss a strategy to use thymic epithelial precursor cells for the regeneration of the thymic microenvironment.
- Open Access
- 1 April 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (7) , 2988-2990
Leydig cell injury as a consequence of an acute graft-versus-host reaction
Hematopoietic stem cell transplantation (HSCT) is associated with significant posttransplantation gonadotoxicity. This deficit has been mainly attributed to pretransplantation conditioning, but lower sperm counts in humans also appear to be associated with graft-versus-host disease (GVHD) following allogeneic HSCT. However, the mechanisms leading to diminished spermatocyte levels during GVHD remain unknown. Here we demonstrate that injury to intratesticular cells occurs in unconditioned F1 mice following the infiltration of donor alloreactive T cells during an acute graft-versus-host reaction (GVHR). Using computer-aided quantitative microscopic morphometry we demonstrate that the nadir of Leydig cell volume density coincides with the peak of intratesticular infiltration by donor T cells. Injury to Leydig cells correlates with an intratesticular inflammatory response characterized by interferon-γ and tumor necrosis factor-α production. These results demonstrate impairment of testosterone-producing Leydig cells during a local alloresponse, thus representing a mechanism that contributes to gonadal insufficiency following allogeneic HSCT.
- 1 April 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (7) , 2988-2990
Open AccessLeydig cell injury as a consequence of an acute graft-versus-host reaction
Hematopoietic stem cell transplantation (HSCT) is associated with significant posttransplantation gonadotoxicity. This deficit has been mainly attributed to pretransplantation conditioning, but lower sperm counts in humans also appear to be associated with graft-versus-host disease (GVHD) following allogeneic HSCT. However, the mechanisms leading to diminished spermatocyte levels during GVHD remain unknown. Here we demonstrate that injury to intratesticular cells occurs in unconditioned F1 mice following the infiltration of donor alloreactive T cells during an acute graft-versus-host reaction (GVHR). Using computer-aided quantitative microscopic morphometry we demonstrate that the nadir of Leydig cell volume density coincides with the peak of intratesticular infiltration by donor T cells. Injury to Leydig cells correlates with an intratesticular inflammatory response characterized by interferon-γ and tumor necrosis factor-α production. These results demonstrate impairment of testosterone-producing Leydig cells during a local alloresponse, thus representing a mechanism that contributes to gonadal insufficiency following allogeneic HSCT.
- Open Access
- 15 June 2004
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (12) , 7359-7367
On the Relevance of TCR Rearrangement Circles as Molecular Markers for Thymic Output during Experimental Graft-versus-Host Disease
Efficient reconstitution of the pool of peripheral T cells after hemopoietic stem cell transplantation (HSCT) is dependent on normal thymic function. However, the development of graft-vs-host disease (GVHD) in the context of allogeneic HSCT is associated with injurious effects on thymocyte development. In this study, we examined in models of syngeneic and allogeneic murine HSCT whether actual posttransplant thymic output is accurately reflected by analysis of signal-joint TCR rearrangement excision circles (sjTRECs). Our data demonstrate that the de novo generation of T cells following syngeneic HSCT of T cell-deficient B6.RAG2−/− (recombination-activating gene 2−/−) mice correlates firmly with an increase of sjTRECs in the thymus and spleen. However, the altered homeostasis of naive peripheral T cells in the presence of GVHD necessitates the combined analysis of cell division in vivo and determinations of sjTREC contents and total sjTREC numbers to draw informative conclusions. From our data, we substantiate that thymic output and peripheral division of newly generated T cells are diminished in the presence of acute GVHD in an experimental radiation/allogeneic HSCT model.
- 15 June 2004
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (12) , 7359-7367
Open AccessOn the Relevance of TCR Rearrangement Circles as Molecular Markers for Thymic Output during Experimental Graft-versus-Host Disease
Efficient reconstitution of the pool of peripheral T cells after hemopoietic stem cell transplantation (HSCT) is dependent on normal thymic function. However, the development of graft-vs-host disease (GVHD) in the context of allogeneic HSCT is associated with injurious effects on thymocyte development. In this study, we examined in models of syngeneic and allogeneic murine HSCT whether actual posttransplant thymic output is accurately reflected by analysis of signal-joint TCR rearrangement excision circles (sjTRECs). Our data demonstrate that the de novo generation of T cells following syngeneic HSCT of T cell-deficient B6.RAG2−/− (recombination-activating gene 2−/−) mice correlates firmly with an increase of sjTRECs in the thymus and spleen. However, the altered homeostasis of naive peripheral T cells in the presence of GVHD necessitates the combined analysis of cell division in vivo and determinations of sjTREC contents and total sjTREC numbers to draw informative conclusions. From our data, we substantiate that thymic output and peripheral division of newly generated T cells are diminished in the presence of acute GVHD in an experimental radiation/allogeneic HSCT model.
- 1 July 2000
- Vol. 96 (1) , 347-54
Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
Reconstitution of the peripheral T-cell compartment is a critical aspect for the success of bone marrow transplantation and is also dependent on the reestablishment of normal thymic structure and function. Graft-versus-host disease (GVHD), however, exacerbates posttransplant immunodeficiency through a deleterious effect on thymic function. To investigate the mechanisms of GVHD-mediated thymic disease, 2 murine parent-->F(1 )transplantation models of acute and chronic GVHD, respectively, were studied. Acute GVHD was associated with changes in thymic architecture and a reduction in cellularity mainly because of the decrease in CD4(+)CD8(+), or double-positive (DP) thymocytes, to less than 15% of values found in mice without GVHD. Simultaneously, mature donor-derived T cells expanded in the confines of the allogeneic thymic microenvironment, leading to local inflammation. Through analysis of in vivo cell proliferation, we demonstrated that the ensuing depletion of DP thymocytes was secondary to a decreased commitment of resident pro-T and pre-T cells to enter the cell cycle. Moreover, DP cells themselves showed altered proliferative capacities in the presence of acute GVHD. These findings suggested that thymic atrophy in acute GVHD is effected by impaired cellular proliferation of immature host thymocytes and that the failure of these cells to enter the cell cycle is dependent on an interferon (IFN)-gamma-driven immune response. In contrast, interleukin-4-driven chronic GVHD was not accompanied by a sustained thymic infiltration of donor T cells. Consequently, there was a lack of apparent structural changes, a restricted in situ transcription of inflammatory cytokines, and a virtually unchanged cell cycle progression in vivo.
- 1 July 2000
- Vol. 96 (1) , 347-54
Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
Reconstitution of the peripheral T-cell compartment is a critical aspect for the success of bone marrow transplantation and is also dependent on the reestablishment of normal thymic structure and function. Graft-versus-host disease (GVHD), however, exacerbates posttransplant immunodeficiency through a deleterious effect on thymic function. To investigate the mechanisms of GVHD-mediated thymic disease, 2 murine parent-->F(1 )transplantation models of acute and chronic GVHD, respectively, were studied. Acute GVHD was associated with changes in thymic architecture and a reduction in cellularity mainly because of the decrease in CD4(+)CD8(+), or double-positive (DP) thymocytes, to less than 15% of values found in mice without GVHD. Simultaneously, mature donor-derived T cells expanded in the confines of the allogeneic thymic microenvironment, leading to local inflammation. Through analysis of in vivo cell proliferation, we demonstrated that the ensuing depletion of DP thymocytes was secondary to a decreased commitment of resident pro-T and pre-T cells to enter the cell cycle. Moreover, DP cells themselves showed altered proliferative capacities in the presence of acute GVHD. These findings suggested that thymic atrophy in acute GVHD is effected by impaired cellular proliferation of immature host thymocytes and that the failure of these cells to enter the cell cycle is dependent on an interferon (IFN)-gamma-driven immune response. In contrast, interleukin-4-driven chronic GVHD was not accompanied by a sustained thymic infiltration of donor T cells. Consequently, there was a lack of apparent structural changes, a restricted in situ transcription of inflammatory cytokines, and a virtually unchanged cell cycle progression in vivo.